Deficient clearance mechanisms of a-synuclein in GBA1 mutants leading to accelerated a-synuclein pathology in cortical areas is thought to underlie the increased rates of cognitive impairment and ultimately, dementia in GBA1-PD patients (Jesus et al. 2016). This evidence concerns the gene GBA1 and dementia.